Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01812278 · ClinicalTrials.gov registry record · NA

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)

A NA study, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
2,637
Enrollment target

NCT01812278 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 2,637 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01812278, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
2,637 participants
Enrollment target

Study Summary

The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

Interventions

  • BEHAVIORAL CBT
  • BEHAVIORAL ACT

Trial Details

FieldValue
Enrollment Target 2,637 participants
Start Date 2014-03-24
Est. Completion 2019-12-31
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT01812278

The ClinicalTrials.gov registry entry for NCT01812278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,637 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which CBT is the first listed.

NCT01812278 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01812278 about?

NCT01812278 is a clinical study titled "Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)". The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

What is the current status of trial NCT01812278?

This trial is currently completed. It is a NA study. The enrollment target is 2,637 participants. The study started on 2014-03-24. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT01812278?

The interventions under investigation include: CBT (BEHAVIORAL), ACT (BEHAVIORAL).

Who is sponsoring clinical trial NCT01812278?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.